Agios Pharmaceuticals, Inc. (AGIO)
29.88
-0.27
(-0.90%)
USD |
NASDAQ |
Nov 17, 16:00
29.88
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Price to Book Value : 1.824 for Nov. 17, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 1.840 |
| November 13, 2026 | 1.928 |
| November 12, 2026 | 1.939 |
| November 11, 2026 | 2.003 |
| November 10, 2026 | 1.939 |
| November 09, 2026 | 1.916 |
| November 06, 2026 | 1.795 |
| November 05, 2026 | 1.726 |
| November 04, 2026 | 1.916 |
| November 03, 2026 | 1.904 |
| November 02, 2026 | 1.828 |
| October 30, 2026 | 1.865 |
| October 29, 2026 | 2.273 |
| October 28, 2026 | 2.327 |
| October 27, 2026 | 2.321 |
| October 26, 2026 | 2.249 |
| October 23, 2026 | 2.259 |
| October 22, 2026 | 2.270 |
| October 21, 2026 | 2.270 |
| October 20, 2026 | 2.237 |
| October 19, 2026 | 2.130 |
| October 16, 2026 | 1.912 |
| October 15, 2026 | 1.973 |
| October 14, 2026 | 1.890 |
| October 13, 2026 | 1.844 |
| Date | Value |
|---|---|
| October 12, 2026 | 1.881 |
| October 09, 2026 | 1.942 |
| October 08, 2026 | 1.948 |
| October 07, 2026 | 1.940 |
| October 06, 2026 | 1.936 |
| October 05, 2026 | 1.908 |
| October 02, 2026 | 1.941 |
| October 01, 2026 | 1.983 |
| September 30, 2026 | 2.030 |
| September 29, 2026 | 1.934 |
| September 28, 2026 | 1.942 |
| September 25, 2026 | 1.893 |
| September 24, 2026 | 1.911 |
| September 23, 2026 | 1.986 |
| September 22, 2026 | 2.032 |
| September 21, 2026 | 1.972 |
| September 18, 2026 | 1.921 |
| September 17, 2026 | 1.952 |
| September 16, 2026 | 1.914 |
| September 15, 2026 | 1.906 |
| September 14, 2026 | 1.930 |
| September 11, 2026 | 1.952 |
| September 10, 2026 | 1.954 |
| September 09, 2026 | 2.012 |
| September 08, 2026 | 1.949 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Protagonist Therapeutics, Inc. | 7.496 |
| Keros Therapeutics, Inc. | 0.8044 |
| ACADIA Pharmaceuticals, Inc. | 2.280 |
| Alnylam Pharmaceuticals, Inc. | 5.815 |
| Anika Therapeutics, Inc. | 1.255 |
Price to Book Value Related Metrics
| PS Ratio | 12.53 |
| Price | 29.88 |
| Earnings Yield | -21.15% |
| Market Cap | 1.786B |